Search F2 TechNotes
Categories
- ASCA Program
- ATEX Directive 2014/34/EU
- Batteries
- CE marking
- Consulting
- EMC Directive 2014/30/EU
- EMC Testing
- EN 60601-1
- EU Battery Regulation (EU)2023/152
- EVs
- FCC
- FDA
- Field Label
- General Product Safety Directive 2001/95/EC
- General Product Safety Regulation (EU) 2023/988
- GPSR
- GPSR (EU)2023/988
- IEC 60601-1-9
- International Testing
- IP Testing
- Lasers
- Listing
- Low Voltage Directive 2014/35/EU
- Machinery Directive 2006/42/EC
- Machinery Regulation (EU)2023/1230
- Medical Devices Regulation (EU)2017/745
- PPE Regulation (EU) 2016/425
- Pressure Equipment Directive 2014/68/EU
- Product Testing
- Prop 65
- R&TTE Directive 1999/5/EC
- Radio Equipment Directive 2014/53/EU
- REACH
- RoHS Directive 2011/65/EU
- SPE-1000
- UKCA
- UL 4200A
- UL 60335-1
- UL 61010-1
- UL 62368-1
- UL 94
- US Field Label
-
Recent Posts
- NFPA 790 vs. NFPA 791: A Field Evaluator’s Guide to This Dynamic Duo
- Why Does EMC Testing of a Medical Device to IEC 60601-1-2, AIM 7351731, and/or Common EM Emitters Testing Have to be Conducted in Both Charging and Battery Modes? (Even When the Device Is Basically Just Napping on the Charger)
- Is My Specially Designed Equipment in the Scope of RoHS?
- Why ISO/IEC 17025 Accreditation Matters for Electrical Safety & EMC Testing | F2 Labs
- We Offer CE Marking Training For Your Organization
Daily Archives: August 23, 2024
The FDA and Common Electromagnetic (EM) Emitters – What You Need to Know
The FDA, per their Guidance Document published June 6, 2022, requires that medical device manufacturers be able to show that their product is immune to common Electromagnetic (EM) Emitters, such as RFID Readers, Near-field Communication (NFC) systems, metal detectors, Electronic … Continue reading
Posted in FDA, Product Testing
Comments Off on The FDA and Common Electromagnetic (EM) Emitters – What You Need to Know